REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 32 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2023. The put-call ratio across all filers is 1.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,044 | -16.4% | 5,132 | +0.3% | 0.00% | – |
| Q2 2023 | $29,974 | +6402.0% | 5,115 | +4550.0% | 0.00% | – |
| Q1 2023 | $461 | -0.4% | 110 | +0.9% | 0.00% | – |
| Q4 2022 | $463 | – | 109 | +55.7% | 0.00% | – |
| Q3 2022 | $0 | – | 70 | -1.4% | 0.00% | – |
| Q2 2022 | $0 | – | 71 | -30.4% | 0.00% | – |
| Q1 2022 | $0 | – | 102 | +5.2% | 0.00% | – |
| Q4 2021 | $0 | – | 97 | +203.1% | 0.00% | – |
| Q3 2021 | $0 | – | 32 | -5.9% | 0.00% | – |
| Q2 2021 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |